Core Laboratories Inc. /DE/ — Director's Dealing 2024

Jan 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2023-12-31

Reporting Person: Daniels Kevin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-31	Common Stock	F	2769	$17.66	Disposed	13180	Direct
2023-12-31	Common Stock	M	7200	—	Acquired	15949	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-31	Performance Shares	$0	M	7200	Disposed		Common Stock (7200)	Direct

Footnotes

F1: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period.